GRI Bio, Inc.
GRI· Nasdaq
Released Apr 1, 2024, before the open
10-Q filed May 10, 2024, 40 days after period end · 0001824293-24-000047
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$1.89M | -$2.15M | -$302.00K | -$2.64M |
| EPS Diluted |
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
| -$101.05 |
| -$15.04 |
| -$11.62 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.